Actualización de la enfermedad de Carrión. C Maguiña Vargas, C Ugarte-Gil, P Breña Chávez, E Ordaya Espinoza, ... Revista médica herediana 19 (1), 36-41, 2008 | 61* | 2008 |
Real-life use of isavuconazole in patients intolerant to other azoles EE Ordaya, GJ Alangaden Clinical Infectious Diseases 63 (11), 1529-1530, 2016 | 30 | 2016 |
Characterization of early-onset severe acute respiratory syndrome coronavirus 2 infection in immunocompromised patients who received tixagevimab-cilgavimab prophylaxis EE Ordaya, E Beam, JD Yao, RR Razonable, P Vergidis Open Forum Infectious Diseases 9 (7), ofac283, 2022 | 17 | 2022 |
Vax-Plasma in Patients With Refractory COVID-19 EE Ordaya, OM Abu Saleh, JR Stubbs, MJ Joyner Mayo Clin Proc 97 (1), 186-189, 2021 | 16 | 2021 |
Infective endocarditis due to Bartonella bacilliformis associated with systemic vasculitis: a case report J Peñafiel-Sam, S Alarcón-Guevara, S Chang-Cabanillas, ... Revista da Sociedade Brasileira de Medicina Tropical 50 (05), 706-708, 2017 | 12 | 2017 |
Compromiso cardiovascular en la fase aguda de la enfermedad de Carrión o bartonelosis humana: 20 años de experiencia en Hospital Nacional Cayetano Heredia C Maguiña Vargas, E Ordaya Espinoza, C Ugarte-Gil, V Franco Reusche, ... Acta Médica Peruana 25 (1), 30-38, 2008 | 11* | 2008 |
Uso racional de antibióticos C Maguiña Vargas Seguro Social de Salud (EsSalud), 2023 | 10 | 2023 |
The Role of Novel Antifungals in the Management of Candidiasis: A Clinical Perspective EE Ordaya, J Clement, P Vergidis Mycopathologia, 2023 | 9 | 2023 |
Genotypic and Predicted Phenotypic Analysis of SARS-CoV-2 Omicron Subvariants in Immunocompromised Patients with COVID-19 Following Tixagevimab-Cilgavimab Prophylaxis EE Ordaya, P Vergidis, RR Razonable, JD Yao, E Beam Journal of Clinical Virology, 2023 | 8 | 2023 |
Bartonellosis: Carrion's Disease and Other Bartonella Infections EE Ordaya, CP Maguiña Hunter's Tropical Medicine and Emerging Infectious Diseases, 604-607, 2020 | 8 | 2020 |
Description of Cryptococcosis following SARS-CoV-2 infection: A disease survey through the Mycosis Study Group Education and Research Consortium (MSG-19) J Walker, T McCarty, G McGwin, EE Ordaya, P Vergidis, ... Clinical Infectious Diseases, 2023 | 5* | 2023 |
Aspergillus osteomyelitis secondary to chronic necrotizing pulmonary aspergillosis in a patient with rheumatoid arthritis EE Ordaya, JR Johnson, DM Drekonja, GE Niehans, AS Kaka Cureus 13 (9), 2021 | 5 | 2021 |
Hemophagocytic lymphohistiocytosis (HLH): elusive diagnosis of disseminated Mycobacterium avium complex infection EE Ordaya, SA Jarir, R Yoo, PH Chandrasekar Germs 7 (3), 149, 2017 | 5 | 2017 |
“Let the Cat Out of the Heart”: Clinical Characteristics of Patients Presenting with Blood Culture-negative Endocarditis due to Bartonella species EE Ordaya, OM Abu Saleh, M Mahmood Open Forum Infectious Diseases, 2023 | 4 | 2023 |
Bartonellosis: Carrion's disease and other Bartonella Infections C Maguiña, EE Ordaya Hunter's Tropical Medicine and Emerging Infectious Disease, 564-567, 2013 | 4 | 2013 |
Real‐world experience of tixagevimab‐cilgavimab pre‐exposure prophylaxis in orthotopic heart transplant recipients EE Ordaya, EM Higgins, P Vergidis, RR Razonable, E Beam Transplant Infectious Disease 25 (3), e14040, 2023 | 3 | 2023 |
Disseminated histoplasmosis and hemophagocytic lymphohistiocytosis in a patient receiving TNF-alpha inhibitor therapy Q Zhong, EE Ordaya, SD Fernandez, K Lescalleet, D Larson, B Pritt, ... IDCases 29, e01603, 2022 | 3 | 2022 |
Novel T2 Magnetic Resonance Assay Compared to Standard Blood Cultures for Detection of Candidemia. S Dwivedi, E Ordaya, B Kezlarian, R Kenny, R Tibbetts, L Samuel, ... Open Forum Infectious Diseases 3 (suppl_1), 1571, 2016 | 3 | 2016 |
Emerging anti-spike monoclonal antibodies against SARS-CoV-2 EE Ordaya, RR Razonable Expert Opinion on Biological Therapy, 2024 | 1 | 2024 |
Temporal trends in antifungal susceptibility of Cryptococcus neoformans isolates from a reference laboratory in the United States, 2011–2021 EE Ordaya, OM Abu Saleh, P Vergidis, SM Deml, NL Wengenack, M Fida Mycoses, 2024 | 1 | 2024 |